This filing reports the initial beneficial ownership of Korro Bio, Inc. (KRRO) by Lynx1 Capital Management LP and Weston Nichols. As of March 31, 2026, Lynx1 Capital Management LP, through its investment manager Lynx1 Capital Management LP and its general partner Lynx1 Capital Management GP LLC, holds 1,537,776 shares ...

This is a Form 3 filing by Julie Ryan, VP of Finance at GH Research PLC, disclosing her initial statement of beneficial ownership in the company. The filing reports ownership of four separate share option grants totaling 247,987 ordinary shares. The options have varying exercise prices and vesting schedules, with expir...

On March 19, 2026, Sino Lion Ventures Limited (Reporting Person) entered into a securities purchase agreement to acquire 259,300 shares of Indaptus Therapeutics, Inc.'s Series AAA Convertible Non-Redeemable Preferred Stock. Each preferred share is convertible into 150 shares of the Issuer's common stock. Following the ...

This SEC Form 3 filing reports the initial beneficial ownership of GH Research PLC (ticker: GHRS) by CEO Velichka Valcheva. The filing discloses four separate share option grants with different vesting schedules and exercise prices. Valcheva was granted options to purchase 685,000 ordinary shares in total, with exercis...